249A — Human Adjust Co Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Human Adjust Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Tanshin |
Standards: | JAS | JAS | — |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 1,374 | 1,953 | 2,558 |
Cost of Revenue | |||
Gross Profit | 374 | 659 | 890 |
Selling / General / Administrative Expenses | |||
Unusual Expense / Income | |||
Other Operating Expenses | |||
Total Operating Expenses | 1,448 | 1,900 | 2,329 |
Operating Profit | -73.2 | 52.8 | 230 |
Gain / Loss on Sale of Assets | |||
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -54.8 | 45 | 211 |
Provision for Income Taxes | |||
Net Income After Taxes | -34.9 | 27.8 | 150 |
Net Income Before Extraordinary Items | |||
Net Income | -34.9 | 27.8 | 150 |
Adjustments to Net Income | |||
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -34.9 | 27.8 | 150 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -91.8 | 136 | 595 |
Dividends per Share |